Real-world checkpoint inhibitor results not as good as trial results
Hematology Oncology News:
- IMRT new standard of care for high-risk cervical cancer: https://bit.ly/3k7ji3y
- Real-world results with checkpoint inhibitors found inferior to trial results: https://bit.ly/35cIt0v
- Are HMAS appropriate for posttransplant maintenance in acute leukemias?: https://bit.ly/3lfqsE7
You can email the show at email@example.com.
Download from Google Play
Download from App Store